Find uplifting stories about heroes, innovations, and solutions
8 results for "mount sinai"
Doctors in New York just became the first in the world to use a newly approved liver cancer treatment that lets them schedule patients on more days of the week. The breakthrough could mean shorter wait times and better access for cancer patients when every day counts.
A groundbreaking Mount Sinai study shows that lung cancer surgery is just as safe for patients 80 and older as it is for younger adults. This finding could transform treatment options for thousands of elderly cancer patients previously considered too frail for surgery.
Scientists discovered why some bladder cancer patients don't respond to immunotherapy by linking common blood markers to immune suppression inside tumors. The breakthrough could help doctors identify resistant cases earlier and develop better combination treatments.
Scientists at Mount Sinai discovered why immunotherapy works for some cancer patients but not others. The breakthrough could help doctors personalize treatment and spare patients from therapies unlikely to help them.
Researchers at Mount Sinai just published the first practical guide helping radiation doctors identify and protect female sexual organs during pelvic cancer treatment. This groundbreaking study addresses a gap in care that's left women's sexual health largely invisible in cancer treatment planning.
Researchers at Mount Sinai created a therapy that doesn't attack cancer cells directly. Instead, it flips the immune cells protecting tumors, transforming defenders into destroyers.
After decades of limited success, cancer vaccines are finally delivering real results thanks to breakthrough genetic technologies that customize treatment to each patient's unique tumor. When combined with other therapies, these personalized vaccines are showing promise across multiple cancer types.
Scientists are testing whether high-intensity workouts combined with anti-inflammatory medications could help people stay healthy longer. The groundbreaking study enrolls adults 65 to 80 in a program designed to fight the chronic inflammation that fuels age-related disease.